Skip to main content
Retour
Watch Compare

Gossamer Bio, Inc.

Qualité des données : 100%
GOSS
Nasdaq Manufacturing Chemicals
0,37 €
▲ 0,03 € (7,46%)
Cap. Boursière: 87,61 M
Prix
0,37 €
Cap. Boursière
87,61 M
Fourchette du Jour
0,34 € — 0,38 €
Fourchette 52 Semaines
0,32 € — 3,87 €
Volume
6 106 899
Ouverture 0,35 €
Moyenne 50J / 200J
1,21 €
69,12% below
Moyenne 50J / 200J
2,16 €
82,69% below

Quick Summary

Points Clés

Negative free cash flow of -171,35 M
Capital efficient — spends only 0,16% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-57,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-80,76%
Net Margin-351,49%
Op. Margin-352,23%

Sécurité

Debt / Equity
N/A
Current Ratio3,28
Interest Coverage-15,54

Valorisation

PE (TTM)
-0,51
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -351,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -57,74% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 48,47 M Net Income (TTM) -170,37 M
ROE N/A ROA -75,76%
Gross Margin N/A Operating Margin -352,23%
Net Margin -351,49% Free Cash Flow (TTM) -171,35 M
ROIC -80,76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,28
Interest Coverage -15,54 Asset Turnover 0,22
Working Capital 141,87 M Tangible Book Value -82,33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,51 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,81
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -195,57%
Market Cap 87,61 M Enterprise Value 78,68 M
Per Share
EPS (Diluted TTM) -0,75 Revenue / Share 0,21
FCF / Share -0,73 OCF / Share -0,73
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,16% FCF Conversion 100,57%
SBC-Adj. FCF -183,84 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 48,47 M 114,70 M — — —
Net Income -170,37 M -56,53 M -179,82 M -229,38 M -234,00 M
EPS (Diluted) -0,75 -0,25 -1,18 -2,71 -3,13
Gross Profit — — — — —
Operating Income -170,73 M -59,92 M -183,76 M -218,59 M -216,12 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 24 000,0 833 000,0 1,61 M 1,83 M 1,74 M
Interest Expense 10,99 M 11,52 M 13,51 M 13,88 M 19,44 M
Income Tax -88 000,0 893 000,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 172,25 M 315,29 M 311,92 M 272,45 M 343,66 M
Total Liabilities 295,01 M 285,80 M 249,15 M 260,37 M 222,19 M
Shareholders' Equity -122,76 M 29,49 M 62,77 M 12,08 M 121,46 M
Total Debt — 0,0 814 000,0 11,99 M 29,08 M
Cash & Equivalents 37,73 M 46,07 M 32,11 M 111,97 M 183,40 M
Current Assets 167,64 M 309,89 M 306,52 M 261,88 M 331,78 M
Current Liabilities 63,44 M 45,01 M 51,60 M 49,23 M 39,86 M